The Meals and Drug Administration has issued an emergency authorization for the usage of the Pfizer-BioNTech COVID-19 vaccine in kids ages 5 to 11.
The FDA’s authorization follows the advice of its unbiased advisory committee, which earlier this week voted almost unanimously in favor of authorizing the vaccine. The committee of 18 voting members voted 17 to zero in favor, with one abstention.
In a day-long assembly Tuesday, advisors pored over knowledge and analyses of the vaccine within the youthful kids, who will obtain two photographs of a 10-microgram dose—a 3rd of the dosage utilized in folks ages 12 years and up—three weeks aside. Knowledge from medical trials counsel that the smaller dose in kids produces equally robust immune responses as these seen in older age teams whereas minimizing the dangers of unintended effects.
Learn 6 remaining paragraphs | Feedback